Post Market Clinical Follow-up of EUROSTEM Femoral Stem
NCT ID: NCT04995822
Last Updated: 2024-02-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
131 participants
OBSERVATIONAL
2021-05-21
2032-11-06
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Hip replacement is intended to provide increased patient mobility and reduce pain by replacing the damages hip joint articulation in patients where there is evidence of sufficient sound bone to seat and support the components.
As part of post market vigilance, EUROS will collect data on EUROSTEM performances and safety
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Post Market Clinical Follow-up of EUROSCUP Fixe Acetabular Cup
NCT05142462
Post Market Clinical Follow-up of Dual-mobility Acetabular Cup EUROSCUP MOBILE
NCT04993638
Prospective and Obsevational Study of Total Hip Prothesis: HYPE Stem
NCT05560022
Avenir Complete Post-Market Clinical Follow-Up Study
NCT04731077
Avenir Müller Hip Stem Post Market Surveillance Study
NCT04079127
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
EUROSTEM femoral stem
All patients who received EUROSTEM femoral stem whatever the version (cemented or cementless)
hip arthroplasty
Hip prosthesis surgery
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
hip arthroplasty
Hip prosthesis surgery
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient informed of its participation to the study
* Patient aged over 18 to date of surgery
Exclusion Criteria
* Patient who refused to participate to the study
* Vulnerable subjects
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
EUROS
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Clinique du Mail
Puilboreau, La Rochelle, France
Clinique Esquirol St Hilaire
Agen, , France
CH Aix en Provence
Aix-en-Provence, , France
Polyclinique du Beaujolais
Arnas, , France
Clinique Montagard
Avignon, , France
Polyclinique du Parc Drevon
Dijon, , France
Clinique du Palais
Grasse, , France
Hôpital privé Drôme Ardèche - Clinique Pasteur
Guilherand-Granges, , France
Clinique Richelieu
Saintes, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EC-309-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.